| Literature DB >> 33029087 |
Ngoc Huy Nguyen1,2, Thong Van Nguyen1, An Quang Nguyen1, Phuong Van Nguyen3, Tuan Ngoc Minh Nguyen1.
Abstract
The COVID-19 pandemic is a novel infectious disease pandemic with the agent SARS-CoV-2 virus which is currently affecting and causing damage globally. The outbreak has been crossing over 200 countries in the world. In the situation of the outbreak of COVID-19, Vietnam has first sixteen typical cases confirmed positive updated to Feb 28th, 2020. After completely applying the medical prevention and active control, Vietnam has the ability to take control of the outbreak of COVID-19 as a recent of WHO assessment. Vietnam has been reported as an effective country for prevention and control the outbreak of COVID-19. We retroactive reviewed our experience with 16 positive cases isolation. This article aims to present the first cohort of COVID-19 patients updated to Feb 28th, 2020 in Vietnam and sharing the national response to the pandemic. © The author(s).Entities:
Keywords: COVID-19; Vietnam; controls the outbreak; experience's lesson; prevention of disease
Mesh:
Year: 2020 PMID: 33029087 PMCID: PMC7532489 DOI: 10.7150/ijms.45449
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Characteristics of first 16 positive patients of COVID-19 in Vietnam
| Characteristics | N | % |
|---|---|---|
| Vinh Phuc | 11 | 68.75% |
| Khanh Hoa | 1 | 6.25% |
| Ho Chi Minh City | 2 | 12.5% |
| Thanh Hoa | 1 | 6.25% |
| Other | 1 | 6.25% |
| Male | 7 | 43.75% |
| Female | 9 | 56.25% |
| Been to Wuhan | 7 | 43.75% |
| Been to China (Wuhan excluded) | 1 | 6.25% |
| Stay local | 8 | 50% |
| Fever | 16 | 100% |
| Cough | 16 | 100% |
| Dyspnea | 16 | 100% |
| Sore throat | 0 | 0% |
| Vomiting | 0 | 0% |
| Diarrhea | 1 | 6.25% |
| Skin hemorrhage | 0 | 0% |
| Rash | 0 | 0% |
| Visit any poultry farm/living animal market/contact to animal | 0 | 0% |
| Contact to suspected people of COVID-19 infection | 8 | 50% |
| Contact to people back from infectious countries of COVID-19 | 5 | 31.25% |
| Contact to people with symptoms of COVID-19 (cough, fever, dyspnea, pneumonia) | 3 | 18.75% |